These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 17956259)

  • 21. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coenzyme A biosynthesis: an antimicrobial drug target.
    Spry C; Kirk K; Saliba KJ
    FEMS Microbiol Rev; 2008 Jan; 32(1):56-106. PubMed ID: 18173393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mono and bis-6-arylbenzimidazo[1,2-c]quinazolines: a new class of antimicrobial agents.
    Rohini R; Shanker K; Reddy PM; Ho YP; Ravinder V
    Eur J Med Chem; 2009 Aug; 44(8):3330-9. PubMed ID: 19371978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, antimicrobial activity and molecular modeling studies of novel benzofuroxan derivatives against Staphylococcus aureus.
    Jorge SD; Masunari A; Rangel-Yagui CO; Pasqualoto KF; Tavares LC
    Bioorg Med Chem; 2009 Apr; 17(8):3028-36. PubMed ID: 19324556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The opportunities and challenges of personalized genome-based molecular therapies for cancer: targets, technologies, and molecular chaperones.
    Workman P
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S45-56. PubMed ID: 12819933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Riboflavin biosynthetic and regulatory factors as potential novel anti-infective drug targets.
    Long Q; Ji L; Wang H; Xie J
    Chem Biol Drug Des; 2010 Apr; 75(4):339-47. PubMed ID: 20148904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties.
    Bruschi M; Pirri G; Giuliani A; Nicoletto SF; Baster I; Scorciapino MA; Casu M; Rinaldi AC
    Peptides; 2010 Aug; 31(8):1459-67. PubMed ID: 20438783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, characterization, in vitro and molecular docking studies of new 2,5-dichloro thienyl substituted thiazole derivatives for antimicrobial properties.
    Sarojini BK; Krishna BG; Darshanraj CG; Bharath BR; Manjunatha H
    Eur J Med Chem; 2010 Aug; 45(8):3490-6. PubMed ID: 20451305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isocyanide-based multicomponent reactions in drug discovery.
    Akritopoulou-Zanze I
    Curr Opin Chem Biol; 2008 Jun; 12(3):324-31. PubMed ID: 18312861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A structure-based approach to ligand discovery for 2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase: a target for antimicrobial therapy.
    Ramsden NL; Buetow L; Dawson A; Kemp LA; Ulaganathan V; Brenk R; Klebe G; Hunter WN
    J Med Chem; 2009 Apr; 52(8):2531-42. PubMed ID: 19320487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antimicrobial activities of 3-O-alkyl analogues of (+)-catechin: improvement of stability and proposed action mechanism.
    Park KD; Cho SJ
    Eur J Med Chem; 2010 Mar; 45(3):1028-33. PubMed ID: 19962795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystallizing new approaches for antimicrobial drug discovery.
    Schmid MB
    Biochem Pharmacol; 2006 Mar; 71(7):1048-56. PubMed ID: 16458857
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-infectives: can cellular screening deliver?
    Keller TH; Shi PY; Wang QY
    Curr Opin Chem Biol; 2011 Aug; 15(4):529-33. PubMed ID: 21723774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives in anti-infective drug design. The late steps in the biosynthesis of the universal terpenoid precursors, isopentenyl diphosphate and dimethylallyl diphosphate.
    Rohdich F; Bacher A; Eisenreich W
    Bioorg Chem; 2004 Oct; 32(5):292-308. PubMed ID: 15381396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design of antimicrobial compounds based on peptide structures.
    Appelt C; Schrey AK; Söderhäll JA; Schmieder P
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2334-7. PubMed ID: 17293110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and synthesis of bile acid-based amino sterols as antimicrobial agents.
    Aher NG; Pore VS; Mishra NN; Shukla PK; Gonnade RG
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5411-4. PubMed ID: 19679476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure-based druggability assessment--identifying suitable targets for small molecule therapeutics.
    Fauman EB; Rai BK; Huang ES
    Curr Opin Chem Biol; 2011 Aug; 15(4):463-8. PubMed ID: 21704549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structures of Leishmania major pteridine reductase complexes reveal the active site features important for ligand binding and to guide inhibitor design.
    Schüttelkopf AW; Hardy LW; Beverley SM; Hunter WN
    J Mol Biol; 2005 Sep; 352(1):105-16. PubMed ID: 16055151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A rational approach to maximize success rate in target discovery.
    Schneider M
    Arch Pharm (Weinheim); 2004 Dec; 337(12):625-33. PubMed ID: 15597396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.